120 related articles for article (PubMed ID: 17407193)
1. Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice.
Kjellev S; Haase C; Lundsgaard D; Ursø B; Tornehave D; Markholst H
Eur J Immunol; 2007 May; 37(5):1397-406. PubMed ID: 17407193
[TBL] [Abstract][Full Text] [Related]
2. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
[TBL] [Abstract][Full Text] [Related]
4. RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.
Totsuka T; Kanai T; Nemoto Y; Tomita T; Okamoto R; Tsuchiya K; Nakamura T; Sakamoto N; Akiba H; Okumura K; Yagita H; Watanabe M
J Immunol; 2009 May; 182(10):6079-87. PubMed ID: 19414759
[TBL] [Abstract][Full Text] [Related]
5. Ameliorating effect of saporin-conjugated anti-CD11b monoclonal antibody in a murine T-cell-mediated chronic colitis.
Kanai T; Uraushihara K; Totsuka T; Nemoto Y; Fujii R; Kawamura T; Makita S; Sawada D; Yagita H; Okumura K; Watanabe M
J Gastroenterol Hepatol; 2006 Jul; 21(7):1136-42. PubMed ID: 16824065
[TBL] [Abstract][Full Text] [Related]
6. Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis.
Totsuka T; Kanai T; Nemoto Y; Tomita T; Tsuchiya K; Sakamoto N; Okamoto R; Watanabe M
Eur J Immunol; 2008 May; 38(5):1275-86. PubMed ID: 18412161
[TBL] [Abstract][Full Text] [Related]
7. Ameliorating effect of anti-inducible costimulator monoclonal antibody in a murine model of chronic colitis.
Totsuka T; Kanai T; Iiyama R; Uraushihara K; Yamazaki M; Okamoto R; Hibi T; Tezuka K; Azuma M; Akiba H; Yagita H; Okumura K; Watanabe M
Gastroenterology; 2003 Feb; 124(2):410-21. PubMed ID: 12557147
[TBL] [Abstract][Full Text] [Related]
8. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus.
Sáez-Borderías A; Gumá M; Angulo A; Bellosillo B; Pende D; López-Botet M
Eur J Immunol; 2006 Dec; 36(12):3198-206. PubMed ID: 17109473
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.
Nemoto Y; Kanai T; Makita S; Okamoto R; Totsuka T; Takeda K; Watanabe M
Gastroenterology; 2007 Jan; 132(1):176-89. PubMed ID: 17241870
[TBL] [Abstract][Full Text] [Related]
12. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
[TBL] [Abstract][Full Text] [Related]
13. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis.
Strauch UG; Obermeier F; Grunwald N; Gürster S; Dunger N; Schultz M; Griese DP; Mähler M; Schölmerich J; Rath HC
Gut; 2005 Nov; 54(11):1546-52. PubMed ID: 15987795
[TBL] [Abstract][Full Text] [Related]
14. Blockade of NKG2D ameliorates disease in mice with collagen-induced arthritis: a potential pathogenic role in chronic inflammatory arthritis.
Andersson AK; Sumariwalla PF; McCann FE; Amjadi P; Chang C; McNamee K; Tornehave D; Haase C; Agersø H; Stennicke VW; Ahern D; Ursø B; Trowsdale J; Feldmann M; Brennan FM
Arthritis Rheum; 2011 Sep; 63(9):2617-29. PubMed ID: 21618462
[TBL] [Abstract][Full Text] [Related]
15. NKG2D function protects the host from tumor initiation.
Smyth MJ; Swann J; Cretney E; Zerafa N; Yokoyama WM; Hayakawa Y
J Exp Med; 2005 Sep; 202(5):583-8. PubMed ID: 16129707
[TBL] [Abstract][Full Text] [Related]
16. Opposing effect of IFNgamma and IFNalpha on expression of NKG2 receptors: negative regulation of IFNgamma on NK cells.
Zhang C; Zhang J; Sun R; Feng J; Wei H; Tian Z
Int Immunopharmacol; 2005 Jun; 5(6):1057-67. PubMed ID: 15829421
[TBL] [Abstract][Full Text] [Related]
17. NK cell regulation of CD4 T cell-mediated graft-versus-host disease.
Noval Rivas M; Hazzan M; Weatherly K; Gaudray F; Salmon I; Braun MY
J Immunol; 2010 Jun; 184(12):6790-8. PubMed ID: 20488796
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells.
Ostberg JR; Dayanc BE; Yuan M; Oflazoglu E; Repasky EA
J Leukoc Biol; 2007 Nov; 82(5):1322-31. PubMed ID: 17711975
[TBL] [Abstract][Full Text] [Related]
19. Ameliorating effect of anti-Fas ligand MAb on wasting disease in murine model of chronic colitis.
Dan N; Kanai T; Totsuka T; Iiyama R; Yamazaki M; Sawada T; Miyata T; Yagita H; Okumura K; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G754-60. PubMed ID: 12969829
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking.
Gur C; Karussis D; Golden E; Doron S; Ilan Y; Safadi R
Clin Immunol; 2006; 118(2-3):307-16. PubMed ID: 16290121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]